Medicare Enrolled
Dr. Mohammed Kanaan
Internal Medicine · Puyallup, WA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kanaan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kanaan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kanaan
Dr. Mohammed Kanaan is an internal medicine specialist in Puyallup, WA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Kanaan performed 77,733 Medicare services across 2,940 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kanaan received a total of $751 from 22 pharmaceutical and/or device companies across 43 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kanaan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 0% volume in WA
$751 industry payments
Medicare Practice Summary
Medicare Utilization ↗77,733
Medicare services
Top 0% in WA for internal medicine
2,940
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,858 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
23,220 | $0 | $2 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
16,320 | $0 | $2 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
12,300 | $0 | $0 |
| Paclitaxel chemotherapy injection | 9,442 | $0 | $0 |
| Pembrolizumab injection (Keytruda) | 4,700 | $40 | $83 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,354 | $0 | $2 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,036 | $7 | $16 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,017 | $8 | $13 |
| Anti-nausea injection (Aloxi/palonosetron) | 870 | $1 | $2 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
754 | $19 | $65 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
578 | $10 | $22 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
556 | $92 | $217 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
350 | $2 | $6 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
349 | $12 | $52 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
349 | $130 | $291 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
330 | $9 | $15 |
| Anti-nausea injection (ondansetron/Zofran) | 328 | $0 | $1 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
262 | $11 | $52 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
243 | $104 | $321 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
194 | $1 | $1 |
| Iron level test | 192 | $6 | $13 |
| Transferrin level test A blood test that measures the amount of transferrin, a protein that binds to and transports iron in the body. |
192 | $12 | $26 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
182 | $13 | $28 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
171 | $6 | $23 |
| PSA test (prostate cancer screening) | 166 | $18 | $37 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
154 | $23 | $75 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
146 | $22 | $75 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
131 | $14 | $30 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
129 | $50 | $150 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
128 | $15 | $31 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
112 | $1 | $1 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
111 | $10 | $36 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
110 | $1 | $2 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
107 | $5 | $12 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
102 | $51 | $158 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
93 | $1 | $2 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 86 | $131 | $368 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
81 | $1 | $8 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
81 | $69 | $70 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
80 | $58 | $148 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
66 | $2 | $4 |
| New patient office visit, complex (60-74 min) | 64 | $167 | $415 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
62 | $26 | $123 |
| Glutamyltransferase (GGT) level test A blood test that measures the level of the liver enzyme glutamyltransferase (GGT) to help evaluate liver health. |
54 | $7 | $15 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
52 | $16 | $48 |
| Direct bilirubin level test A blood test that measures the amount of direct bilirubin in your body. Direct bilirubin is the form of the waste product processed by the liver. |
48 | $5 | $11 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
39 | $93 | $212 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $65 | $146 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
36 | $27 | $100 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
33 | $16 | $33 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
33 | $55 | $140 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
27 | $18 | $55 |
| Liver function blood test panel | 20 | $8 | $17 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
18 | $137 | $408 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
13 | $35 | $90 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
12 | $20 | $45 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
12 | $141 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
22.2% high complexity
69.5% medium
8.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$751
Total received (2018-2024)
Avg $107/year across 7 years
Top 30% in WA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
43
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$687 (91.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$64 (8.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$180
2023
$66
2022
$90
2021
$12
2020
$37
2019
$51
2018
$316
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Tempus AI, Inc
$104
Sumitomo Pharma America, Inc.
$43
ABBVIE INC.
$34
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$123
Tempus AI, Inc
$104
E.R. Squibb & Sons, L.L.C.
$54
Merck Sharp & Dohme Corporation
$54
GlaxoSmithKline, LLC.
$50
Sumitomo Pharma America, Inc.
$43
Incyte Corporation
$43
PFIZER INC.
$39
ABBVIE INC.
$34
Genentech USA, Inc.
$26
Pharmacyclics LLC, an AbbVie Company
$24
Exelixis Inc.
$23
Rigel Pharmaceuticals, Inc.
$21
Pharmacyclics LLC, An AbbVie Company
$16
Coherus Biosciences Inc.
$15
Eisai Inc.
$14
Daiichi Sankyo Inc.
$13
Amgen Inc.
$12
Gilead Sciences, Inc.
$12
Celgene Corporation
$11
Lilly USA, LLC
$11
Clovis Oncology, Inc.
$10
Top 3 companies account for 37.4% of all-time payments
Associated products mentioned in payments ›
AFINITOR · CYRAMZA · Cabometyx · EPKINLY · GAZYVA · IBRANCE · IMBRUVICA · INJECTAFER · JADENU · JAKAFI · KEYTRUDA · Kyprolis · Lenvima · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Perjeta · Revlimid · Rubraca · SUTENT · Tavalisse · Udenyca · VOTRIENT · XT CDX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
606
Per 100K population
65.6
County median income
$96,632
Nearest hospital
MULTICARE GOOD SAMARITAN HOSPITAL
5.0 mi
5.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kanaan is a mixed practice specialist, with above-average Medicare volume (top 0% in WA), with low-engagement industry engagement, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kanaan experienced with filgrastim injection (nivestym) for white blood cells?
Based on Medicare claims data, Dr. Kanaan performed 23,220 filgrastim injection (nivestym) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kanaan receive payments from pharmaceutical companies?
Yes. Dr. Kanaan received a total of $751 from 22 companies across 43 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kanaan's costs compare to other internal medicine physicians in Puyallup?
Dr. Kanaan's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kanaan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Puyallup
Browse internal medicine physicians in Puyallup ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in WA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in WA
Which WA internal medicine physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Tempus AI, Inc Payments to Doctors
See all physicians who received payments from Tempus AI, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology